miR-101 targets the 3′UTRs of DNA-PK and ataxia telangiectasia mutated (ATM) mRNAs to influence both the non-homologous end joining (NHEJ) and homologous recombination (HR) DNA damage repair processes and to sensitize tumor cells to radiation18. Here, ATM is linked to neoplasm.